Volume 69 Received 5 November 2012 | ||||||||||
| ||||||||||
aInstitute of Nuclear Chemistry and Technology, Dorodna 16, 03-195 Warsaw, Poland
Correspondence e-mail: k.lyczko@ichtj.waw.pl
The asymmetric unit of the title compound, C11H12N2O·C25H28N4O2, contains two different molecules. The smaller is known as antipyrine [systematic name: 1,5-dimethyl-2-phenyl-1H-pyrazol-3(2H)-one] and the larger is built up from two antypirine molecules which are connected through a C atom of the pyrazolone ring to a central propanyl part [systematic name: 4,4'-(propane-2,2-diyl)bis[1,5-dimethyl-2-phenyl-1H-pyrazol-3(2H)-one]. Intramolecular C-H
O hydrogen bonds occur in the latter molecule. In the crystal, C-H
O hydrogen bonds link the molecules into a two-dimensional network parallel to (001).
Structural data on metal complexes with antipyrine were reported by Vijayan & Viswamitra (1966
); Biagini Cingi et al. (1972
); Baker & Jeffery (1974
); Brassy et al. (1974
); Mahadevan et al. (1984
); Rheingold & King (1989
) and Su et al. (2000
). For related structures, see: Singh & Vijayan (1973
); Panneerselvam et al. (1996
); Merz (2002
); Yuchi et al. (1991
). Some properties of antipyrine and its derivatives were described by Peter et al. (1991
).
|
|
|
Data collection: CrysAlis PRO (Agilent, 2010
); cell refinement: CrysAlis PRO; data reduction: CrysAlis PRO; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008
); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008
); molecular graphics: XP in SHELXTL (Sheldrick, 2008
) and Mercury (Macrae et al., 2008
); software used to prepare material for publication: SHELXL97.
Supplementary data and figures for this paper are available from the IUCr electronic archives (Reference: KJ2216 ).
The author thanks the Institute of Nuclear Chemistry and Technology for financial support.
Agilent (2010). CrysAlis PRO. Agilent Technologies, Yarnton, England.
Baker, R. W. & Jeffery, J. W. (1974). J. Chem. Soc. Dalton Trans. pp. 229-232. ![[CrossRef]](../../../../../../logos/crossrefborder.gif)
Brassy, C., Renaud, A., Delettré, J. & Mornon, J.-P. (1974). Acta Cryst. B30, 2246-2248.
![[ISI]](../../../../../../logos/isiborder.gif)
Cingi, M. B., Guastini, C., Musatti, A. & Nardelli, M. (1972). Acta Cryst. B28, 667-672.
![[ISI]](../../../../../../logos/isiborder.gif)
Macrae, C. F., Bruno, I. J., Chisholm, J. A., Edgington, P. R., McCabe, P., Pidcock, E., Rodriguez-Monge, L., Taylor, R., van de Streek, J. & Wood, P. A. (2008). J. Appl. Cryst. 41, 466-470.
![[details]](../../../../../../j/graphics/details.gif)
Mahadevan, C., Radha, A. & Seshasayee, M. (1984). Z. Kristallogr. 169, 159-163.
![[ChemPort]](../../../../../../logos/chemportborder.gif)
Merz, K. (2002). Acta Cryst. E58, o338-o340.
![[details]](../../../../../../e/graphics/details.gif)
Panneerselvam, K., Jayanthi, N., Rudiño-Piñera, E. & Soriano-García, M. (1996). Acta Cryst. C52, 1257-1258.
![[details]](../../../../../../c/graphics/details.gif)
Peter, J. V. St., Abul-Hajj, Y. & Awni, W. M. (1991). Pharm. Res. 8, 1470-1476. ![[PubMed]](../../../../../../logos/pubmedborder.gif)
Rheingold, A. L. & King, W. (1989). Inorg. Chem. 28, 1715-1719.
![[ISI]](../../../../../../logos/isiborder.gif)
Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.
![[details]](../../../../../../a/graphics/details.gif)
Singh, T. P. & Vijayan, M. (1973). Acta Cryst. B29, 714-720.
![[ISI]](../../../../../../logos/isiborder.gif)
Su, C.-Y., Yang, X.-P., Xu, A.-W., Zhang, Z.-F., Liu, H.-K. & Kang, B.-S. (2000). Acta Cryst. C56, e82-e83.
![[details]](../../../../../../c/graphics/details.gif)
Vijayan, M. & Viswamitra, M. A. (1966). Acta Cryst. 21, 522-532.
![[details]](../../../../../../q/graphics/details.gif)
Yuchi, A., Shiro, M., Wada, H. & Nakagawa, G. (1991). Bull. Chem. Soc. Jpn, 64, 760-765.
![[ISI]](../../../../../../logos/isiborder.gif)